AWARDS
GATACA wins commercialization award from Virginia's Center of Innovative Technology (CIT) to offer a first version of GAT/ML on the GATACA website.
06/2020
GAT for NGS: A Bioinformatics Tool for HBV Quasispecies – Incorporating Machine Learning
GATACA wins Phase I SBIR award from the NIH (NIAID) to develop machine learning features into GAT.
03/2020
Development of a joint machine learning/de novo assembly system for resolving viral quasispecies.
GATACA wins Phase I SBIR award from the NIH (NIAID) to develop GAT.
02/2016
Development of a tool for the whole genome de novo assembly of hepatitis B virus (HBV) populations.
GATACA wins SBIR matching funds award from the Center for Innovative Technology (CIT).
07/2012
GATACA wins Phase II SBIR award from the NIH (NIAID) to develop HepCbase (web-based).
03/2012
Integrated software application for management of Hepatitis C Virus data.
GATACA wins Phase I SBIR award from the NIH (NIAID) to develop HepCbase desktop.
03/2010
Desktop application for management and analysis of Hepatitis C Virus data.
GATACA wins Phase I SBIR award from the NSF to develop HCV analytics.
01/2005
Desktop tools for management of Hepatitis C Virus data.
ANNOUNCEMENTS
GAT pipeline analyzes HBV patient NGS for case-study presentation and publication.
08/2020
GATACA, in collaboration with the LOBP (Emory) and University of São Paulo School of Medicine co-authors an abstract to be presented at EASL, London and manuscript for publication:
Multivariant surface quasispecies in a hepatitis B virus chronically infected individual with concomitant and continually positive surface antigen and -anti-HBs biomarkers.
Ono S.K.,Craig J.C.,Bassit L., Abreu R.M., Ganova-Raeva L.,Khudyakov Y.,Gonzalez D., Carrilho F.J.,Schinazi R.F.
GATACA releases Application Note announcing new de novo GAT for HBV.
11/2018
Presented at the 2018 Annual Forum for HBV Research in Washington D.C.
GATACA co-authors publication on HCV.
07/2017
Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C.
Keshvari M., Alavian S.M., Behnava B., Pouryasin A., Craig J.C., Sharafi H. J Clin Lab Anal.
GATACA is invited to join the Bioinformatics Working Group of The Forum for Collaborative HIV Research.
05/2013
GATACA becomes a member of interactive bioinformatics roundtable meetings, and HepCbase served as the hub for upload and management of HIV NGS data.
